REFINE data showed patients with resistant and refractory migraine have a higher burden of comorbidities than those with nonresistant and nonrefractory migraine.
The new findings from the drug candidate deals a blow to the Danish drugmaker’s ambitions for a successor to its popular Wegovy more powerful than Eli Lilly’s Zepbound.
The median age was 61 (IQR, 55-68) years, 69% were men, and 53% of patients with ALD had cirrhosis. At least 1 comorbidity was observed in 80% of patients with ALD vs 58% of comparators. Low physical ...
Vaccination against COVID-19 reduces the incidence of hospitalization or death and the development of severe disease among those with a breakthrough infection.